Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,529 | 48,044 | 63,745 | 58,181 | 40,219 |
| Marketable Securities | 200 | 8,045 | 10,695 | 450 | 8,825 |
| Receivables | N/A | N/A | 981 | 683 | 595 |
| Inventories | N/A | N/A | 161 | 171 | 116 |
| TOTAL | $15,171 | $56,815 | $76,848 | $60,360 | $50,675 |
| Non-Current Assets | |||||
| PPE Net | 112 | 507 | 1,096 | 2,040 | 3,291 |
| Intangibles | 322 | 452 | 712 | 1,850 | 3,755 |
| TOTAL | $434 | $959 | $1,808 | $3,890 | $7,046 |
| Total Assets | $15,605 | $57,774 | $78,656 | $64,250 | $57,721 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 808 | 1,707 | 1,219 | 848 | 1,268 |
| Accrued Expenses | 3,759 | 7,788 | 4,614 | 3,112 | 4,730 |
| TOTAL | $4,567 | $9,495 | $5,833 | $5,305 | $15,952 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 1,345 | 9,954 |
| Other Non-Current Liabilities | 354 | 578 | 949 | 497 | 621 |
| TOTAL | $354 | $578 | $949 | $7,218 | $50,519 |
| Total Liabilities | $4,921 | $10,073 | $6,782 | $12,523 | $66,471 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54 | 45 | 45 | 37 | 26 |
| Common Shares | 63 | 63 | 63 | 52 | 36 |
| Retained earnings | -455,360 | -413,249 | -386,174 | -352,880 | -368,174 |
| TOTAL | $10,684 | $47,701 | $71,874 | $51,727 | $-8,750 |
| Total Liabilities And Equity | $15,605 | $57,774 | $78,656 | $64,250 | $57,721 |